Cartesian Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -65.9% | -65.9% | -40.5% |
| FY2017 | -126.1% | -126.1% | -64.6% |
| FY2018 | 1,205.9% | 1,205.9% | -146.9% |
| FY2019 | -659.2% | -659.2% | -55.6% |
| FY2020 | 382.5% | 382.5% | -41.6% |
| FY2021 | -114.1% | -114.1% | -16.1% |
| FY2022 | 37.7% | 37.7% | 21.3% |
| FY2023 | 49.9% | 49.9% | -72.0% |
| FY2024 | 1,138.3% | 1,138.3% | -17.8% |
| FY2025 | 103.2% | 103.2% | -44.0% |